Oleg Khaykin
Analyst · Stifel
Sure. So, I would say, I mean maybe if before I go by geography, I'll talk first about the different businesses. So, I would say anything to do with lab and production continue to be pretty strong and healthy as most manufacturing operations and engineering labs continue to operate throughout the pandemic. It by the way, also includes our internal labs, all our engineers are back at work. Obviously, we implemented various safety protocols, but if I look at our own internal engineering labs and our manufacturing facilities, they continue to operate with no interruption, and we're seeing the same thing pretty much with all our major customers. So, those two segments were quite good, and we expect them to continue to do fine. I mean the only thing I would say is the conversion cycle from design win to appeal is a little longer, because you have to ship the equipment to the customer, you cannot enter their facilities because they're quarantined, but you have to do everything remotely. So, it takes a bit more time, but that flow of business continues to be pretty strong. The area where we saw weakness towards the end of Q3 and through most of the Q4 is the field operations, and it's largely because of the disruption to a lot of the operators, but throughout the summer, we've been seeing stabilization as more and more of them send their technicians back in the field, and they kind of got their act together and kind of found the new normal and gradually, they're all reassessing what they need to do, and I actually do think, given the plethora of challenges, the lot of operators are facing with different work-from-home environment, it will be very positive for our field instrumentation business in quarters to come. In case of OSP, one of the things we saw in Q3 and Q4, a lot of the governmental printer operations have been shutdown, so the currencies were not printed. So, a lot of the inventories of finished notes have been depleted, and a lot of the inventories of whatever raw materials in the channel were depleted. So, as such, starting this quarter, and I think for the next several quarters, I expect demand for anti-counterfeiting products to be running above our average, which combined with a fairly strong 3D sensing demand that we see coming in the coming quarters would be a very -- it will lead to kind of record performance for our OSP business unit. So, in that respect, I think our OSP business unit is almost countercyclical to some of the challenges we faced in NSE business units. So, that's a welcome outlook there. In terms of geographies, I would say Asia-Pacific kind of saw the initial brunt of the coronavirus. So, that was kind of the canary in the mineshaft. We saw the initial decline and also a shutdown of facilities there; mostly end of January through February. Since then, pretty much most of the Asia-Pacific operations have recovered, although there is still obviously continued some challenges COVID-related, but in terms of manufacturing and lab and engineering, and production demand in that region, it all continues to be pretty well. Europe surprisingly kept its resiliency, even during the worst of the crisis, and I mean the only obviously challenge is converting design wins to POs takes a bit longer, given the remote work environment, but Europe was pretty good. North America had some stumbles in March, April, May, but things starting to stabilize and recover throughout the summer. One region that's really been impacted heavily is Latin and South America, and that is driven -- obviously COVID is a big influencer there, but also a significant devaluation of currency presented challenges for a number of customers. Now, luckily for us, it's a very small part of our business, but nevertheless, if I would say geographically, I'd say Central and South America have really been the regions that have been most impacted by combination of COVID and economic challenges. So, hopefully, that gives you some color on regional as well as the different business product lines.